Pathkey.AIASX:PKY +18.33% Pretax Margin % is -6,770.00% as of Dec. 2025. The stock has 10 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Pathkey.AI ranks better than 99.85% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pathkey.AI's Pre-Tax Income for the
six
months ended in Dec. 2025 was A$-0.68 Mil. Pathkey.AI's Revenue for the
six
months ended in Dec. 2025 was A$0.01 Mil. Therefore, Pathkey.AI's pretax margin for the quarter that ended in Dec. 2025 was -6,770.00%.
The historical rank and industry rank for Pathkey.AI's Pretax Margin % or its related term are showing as below:
ASX:PKY'
s Pretax Margin % Range Over the Past 10 Years
Min: -10862.5 Med: -555.71 Max: 36050
Current: 36050
ASX:PKY's Pretax Margin % is ranked better than 99.85% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 4
vs ASX:PKY: 36050.00
Pathkey.AI (ASX:PKY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Pathkey.AI Pretax Margin % Related Terms
Pathkey.AI Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Pathkey.AI's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PKY vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, Pathkey.AI's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pathkey.AI Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pathkey.AI's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Pathkey.AI's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pathkey.AI (ASX:PKY) has a Pretax Margin % of -6,770.00% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pathkey.AI and its competitors. According to the industry distribution chart, Pathkey.AI ranks #1 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Pathkey.AI's Pretax Margin % too high?
Pathkey.AI's current Pretax Margin % is -6,770.00%. Based on the distribution chart, Pathkey.AI ranks #1 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Pathkey.AI's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pathkey.AI ranks #1 out of 665 companies for Pretax Margin %. This places Pathkey.AI in the top 0% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pathkey.AI and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pathkey.AI's current Pretax Margin % is -6,770.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pathkey.AI stock overvalued right now?
Pathkey.AI (ASX:PKY) has a current Pretax Margin % of -6,770.00%. The current Pretax Margin % is -6,770.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pathkey.AI (ASX:PKY), the current Pretax Margin % is -6,770.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pathkey.AI Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients. The group's main revenue streams are Retainer revenue and Project revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PKY has been successfully added to your 